Genetic Technologies Ltd (NASDAQ:GENE)

3.95
Delayed Data
As of May 27
 -0.02 / -0.50%
Today’s Change
1.04
Today|||52-Week Range
11.00
+105.14%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues4.6M3.8M3.5M4.2M
 
 
 
 
 
Cost of Goods Sold5.9M3.1M4.2M1.6M
 
 
 
 
 
Depreciation And Amortization617.3K583.9K407.1K310.7K
 
 
 
 
 
 
Operating ExpensesGross Income-1.9M174.0K-1.2M2.3M
 
 
 
 
 
General Expenses10.5M14.1M13.2M12.5M
 
 
 
 
 
Research And Development4.4M4.0M3.4M2.9M
 
 
 
 
 
Total Operating Expenses17.0M17.8M17.9M14.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-12.4M-14.0M-14.4M-10.2M
 
 
 
 
 
Extraordinary Credit--5.3M--0.00
 
 
Extraordinary Charge-269.2K-108.4K---323.9K
 
 
 
 
Interest Expense On Debt82.0K47.0K39.8K683.2K
 
 
 
 
 
Equity In Earnings0.00-137.2K-446.9K-332.9K
 
 
 
 
Other Expenses13.4M2.8M4.9M1.8M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income880.4K-5.4M-9.3M-9.3M
 
 
 
 
 
Income Taxes0.000.00-185.0K-329.0K
 
 
 
Minority Interest-8.7K-9.7K-52.2K-8.5K
 
 
 
 
 
Discontinued Operations21.6K0.000.000.00
 
 
Net Income910.6K-5.5M-9.5M-9.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS2.7M3.1M3.1M3.8M
 
 
 
 
 
Shares To Calculate EPS Diluted2.7M3.1M3.1M3.8M
 
 
 
 
 
 
Earnings Per ShareEPS$0.33-$1.79-$3.02-$2.42
 
 
 
 
 
EPS Diluted$0.33-$1.79-$3.02-$2.42
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account